Abstract
Novel 3-hydroxy-3-phenylpropanoate ester–azidothymidine (AZT) conjugates have been prepared using Baylis–Hillman methodology, and their potential as dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors has been explored using enzyme inhibition and computer modelling techniques; their activity and HeLa cell toxicity have been compared with those of their cinnamate ester analogues.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have